GSK PLC (GSK)
43.41
+0.84
(+1.97%)
USD |
NYSE |
May 02, 15:28
GSK Price to Book Value: 5.216 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 01, 2024 | 5.115 |
April 30, 2024 | 4.979 |
April 29, 2024 | 5.000 |
April 26, 2024 | 4.940 |
April 25, 2024 | 4.916 |
April 24, 2024 | 4.910 |
April 23, 2024 | 4.955 |
April 22, 2024 | 4.877 |
April 19, 2024 | 4.776 |
April 18, 2024 | 4.719 |
April 17, 2024 | 4.758 |
April 16, 2024 | 4.800 |
April 15, 2024 | 4.866 |
April 12, 2024 | 4.886 |
April 11, 2024 | 4.902 |
April 10, 2024 | 4.889 |
April 09, 2024 | 4.912 |
April 08, 2024 | 4.908 |
April 05, 2024 | 4.949 |
April 04, 2024 | 4.910 |
April 03, 2024 | 4.991 |
April 02, 2024 | 5.021 |
April 01, 2024 | 5.097 |
March 28, 2024 | 5.151 |
March 27, 2024 | 5.166 |
Date | Value |
---|---|
March 26, 2024 | 5.142 |
March 25, 2024 | 5.146 |
March 22, 2024 | 5.089 |
March 21, 2024 | 5.056 |
March 20, 2024 | 5.004 |
March 19, 2024 | 5.050 |
March 18, 2024 | 5.029 |
March 15, 2024 | 5.035 |
March 14, 2024 | 5.141 |
March 13, 2024 | 5.175 |
March 12, 2024 | 5.164 |
March 11, 2024 | 5.122 |
March 08, 2024 | 5.148 |
March 07, 2024 | 5.201 |
March 06, 2024 | 5.086 |
March 05, 2024 | 5.084 |
March 04, 2024 | 5.065 |
March 01, 2024 | 5.016 |
February 29, 2024 | 5.000 |
February 28, 2024 | 5.052 |
February 27, 2024 | 5.057 |
February 26, 2024 | 5.052 |
February 23, 2024 | 5.038 |
February 22, 2024 | 5.031 |
February 21, 2024 | 5.005 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.935
Minimum
Sep 27 2022
18.84
Maximum
Sep 03 2019
5.888
Average
4.985
Median
Price to Book Value Benchmarks
AstraZeneca PLC | 6.292 |
Novo Nordisk A/S | 35.32 |
Pfizer Inc | 1.760 |
Sanofi SA | 1.506 |
Moderna Inc | 3.512 |
Price to Book Value Related Metrics
PE Ratio | 15.53 |
PS Ratio | 2.506 |
Price to Free Cash Flow | 17.18 |
Price | 43.41 |
Earnings Yield | 6.44% |
Market Cap | 88.69B |
Operating PE Ratio | 10.36 |
Normalized PE Ratio | 14.19 |